Effects of exercise training on gut hormone levels after a single bout of exercise in middle-aged Japanese women

SpringerPlus

Volumn 2, Issue 1, 2013, Pages 1-9

  Ueda, Shin ya ^a   Miyamoto, Tadayoshi ^a   Nakahara, Hidehiro ^a   Shishido, Toshiaki ^b   Usui, Tatsuya ^c   Katsura, Yoshihiro ^d   Yoshikawa, Takahiro ^e   Fujimoto, Shigeo ^e  

^a MORINOMIYA UNIVERSITY OF MEDICAL SCIENCES   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c Department of Elementary and Preschool Education   (Japan)

^d KOGAKUIN UNIVERSITY   (Japan)

^e OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Exercise training; Ghrelin; Glucagon like peptide 1; Peptide YY

Indexed keywords

EID: 84876559248     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-2-83     Document Type: Article

References (42)

1. Barrera JG, Sandoval DA, D'Alessio DA, Seeley RJ (2011) GLP-1 and energy balance: an integrated model of short-term and long-term control. Nat Rev Endocrinol 7:507-516
2. Borg GA (1973) Perceived exertion: a note on "history" and methods. Med Sci Sports 5:90-93
3. Broom DR, Batterham RL, King JA, Stensel DJ (2009) Influence of resistance and aerobic exercise on hunger, circulating levels of acylated ghrelin, and peptide YY in healthy males. Am J Physiol Regul Integr Comp Physiol 296:R29-R35
4. Chanoine JP, Mackelvie KJ, Barr SI, Wong AC, Meneilly GS, Elahi DH (2008) GLP-1 and appetite responses to a meal in lean and overweight adolescents following exercise. Obesity (Silver Spring) 16:202-204
5. Cheng MH, Bushnell D, Cannon DT, Kern M (2009) Appetite regulation via exercise prior or subsequent to high-fat meal consumption. Appetite 52:193-198
6. Derosa G, Maffioli P (2012) Anti-obesity drugs: a review about their effects and their safety. Expert Opin Drug Saf 11:459-471
7. Donnelly JE, Kirk EP, Jacobsen DJ, Hill JO, Sullivan DK, Johnson SL (2003) Effects of 16 mo of verified, supervised aerobic exercise on macronutrient intake in overweight men and women: the Midwest Exercise Trial. Am J Clin Nutr 78:950-956
8. Field BC, Chaudhri OB, Bloom SR (2009) Obesity treatment: novel peripheral targets. Br J Clin Pharmacol 68:830-843
9. Flint A, Raben A, Blundell JE, Astrup A (2000) Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 24:38-48
10. Foster-Schubert KE, McTiernan A, Frayo RS, Schwartz RS, Rajan KB, Yasui Y, Tworoger SS, Cummings DE (2005) Human plasma ghrelin levels increase during a one-year exercise program. J Clin Endocrinol Metab 90:820-825
11. Fumeron F, Durack-Bown I, Betoulle D, Cassard-Doulcier AM, Tuzet S, Bouillaud F, Melchior JC, Ricquier D, Apfelbaum M (1996) Polymorphisms of uncoupling protein (UCP) and beta 3 adrenoreceptor genes in obese people submitted to a low calorie diet. Int J Obes Relat Metab Disord 20:1051-1054
12. Gallwitz B (2012) Anorexigenic effects of GLP-1 and its analogues. Handb Exp Pharmacol 209:185-207
13. Jones TE, Basilio JL, Brophy PM, McCammon MR, Hickner RC (2009) Long-term exercise training in overweight adolescents improves plasma peptide YY and resistin. Obesity (Silver Spring) 17:1189-1195
14. Karra E, Batterham RL (2010) The role of gut hormones in the regulation of body weight and energy homeostasis. Mol Cell Endocrinol 316:120-128
15. Kelishadi R, Hashemipour M, Mohammadifard N, Alikhassy H, Adeli K (2008) Short-and long-term relationships of serum ghrelin with changes in body composition and the metabolic syndrome in prepubescent obese children following two different weight loss programmes. Clin Endocrinol (Oxf) 69:721-729
16. Kelly KR, Brooks LM, Solomon TP, Kashyap SR, O'Leary VB, Kirwan JP (2009) The glucose-dependent insulinotropic polypeptide and glucose-stimulated insulin response to exercise training and diet in obesity. Am J Physiol Endocrinol Metab 296:E1269-E1274
17. Kim HJ, Lee S, Kim TW, Kim HH, Jeon TY, Yoon YS, Oh SW, Kwak H, Lee JG (2008) Effects of exercise-induced weight loss on acylated and unacylated ghrelin in overweight children. Clin Endocrinol (Oxf) 68:416-422
18. King NA (1999) What processes are involved in the appetite response to moderate increases in exercise-induced energy expenditure? Proc Nutr Soc 58:107-113
19. Kogure A, Yoshida T, Sakane N, Umekawa T, Takakura Y, Kondo M (1998) Synergic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on weight loss in obese Japanese. Diabetologia 41:1399
20. Konopko-Zubrzycka M, Baniukiewicz A, Wróblewski E, Kowalska I, Zarzycki W, Górska M, Dabrowski A (2009) The effect of intragastric balloon on plasma ghrelin, leptin, and adiponectin levels in patients with morbid obesity. J Clin Endocrinol Metab 94:1644-1649
21. Leidy HJ, Gardner JK, Frye BR, Snook ML, Schuchert MK, Richard EL, Williams NI (2004) Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal-weight young women. J Clin Endocrinol Metab 89:2659-2664
22. Mackelvie KJ, Meneilly GS, Elahi D, Wong AC, Barr SI, Chanoine JP (2007) Regulation of appetite in lean and obese adolescents after exercise: role of acylated and desacyl ghrelin. J Clin Endocrinol Metab 92:648-654
23. Martins C, Morgan LM, Bloom SR, Robertson MD (2007) Effects of exercise on gut peptides, energy intake and appetite. J Endocrinol 193:251-258
24. Martins C, Kulseng B, King NA, Holst JJ, Blundell JE (2010) The effects of exerciseinduced weight loss on appetite-related peptides and motivation to eat. J Clin Endocrinol Metab 95:1609-1616
25. Mizia-Stec K, Zahorska-Markiewicz B, Olszanecka-Glinianowicz M, Janowska J, Mucha Z, Holecki M, Gasiora Z (2008) Ghrelin as a potential blood pressure reducing factor in obese women during weight loss treatment. Endokrynol Pol 59:207-211
26. Morpurgo PS, Resnik M, Agosti F, Cappiello V, Sartorio A, Spada A (2003) Ghrelin secretion in severely obese subjects before and after a 3-week integrated body mass reduction program. J Endocrinol Invest 26:723-727
27. Neary MT, Batterham RL (2009) Gut hormones: implications for the treatment of obesity. Pharmacol Ther 124:44-56
28. Nguyen AD, Herzog H, Sainsbury A (2011) Neuropeptide Y and peptide YY: important regulators of energy metabolism. Curr Opin Endocrinol Diabetes Obes 18:56-60
29. Potteiger JA, Jacobsen DJ, Donnelly JE, Hill JO (2003) Midwest Exercise Trial. Glucose and insulin responses following 16 months of exercise training in overweight adults: the Midwest Exercise Trial. Metabolism 52:1175-1181
30. Rawson ES, Nolan A, Silver K, Shuldiner AR, Poehlman ET (2002) No effect of the Trp64Arg beta(3)-adrenoceptor gene variant on weight loss, body composition, or energy expenditure in obese, caucasian postmenopausal women. Metabolism 51:801-805
31. Roth CL, Enriori PJ, Harz K, Woelfle J, Cowley MA, Reinehr T (2005) Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss. J Clin Endocrinol Metab 90:6386-6391
32. Sakane N, Yoshida T, Umekawa T, Kogure A, Takakura Y, Kondo M (1997) Effects of Trp64Arg mutation in the beta 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care 20:1887-1890
33. Santosa S, Demonty I, Lichtenstein AH, Cianflone K, Jones PJ (2007) An investigation of hormone and lipid associations after weight loss in women. J Am Coll Nutr 26:250-258
34. Schellekens H, Finger BC, Dinan TG, Cryan JF (2012) Ghrelin signalling and obesity: At the interface of stress, mood and food reward. Pharmacol Ther 135:316-326
35. Shiwaku K, Nogi A, Anuurad E, Kitajima K, Enkhmaa B, Shimono K, Yamane Y (2003) Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta3-adrenergic receptor gene. Int J Obes Relat Metab Disord 27:1028-1036
36. Tchernof A, Starling RD, Turner A, Shuldiner AR, Walston JD, Silver K, Poehlman ET (2000) Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant. Diabetes 49:1709-1713
37. Torekov SS, Madsbad S, Holst JJ (2011) Obesity-an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential. Obes Rev 12:593-601
38. Ueda SY, Yoshikawa T, Katsura Y, Usui T, Fujimoto S (2009a) Comparable effects of moderate intensity exercise on changes in anorectic gut hormone levels and energy intake to high intensity exercise. J Endocrinol 203:357-364
39. Ueda SY, Yoshikawa T, Katsura Y, Usui T, Nakao H, Fujimoto S (2009b) Changes in gut hormone levels and negative energy balance during aerobic exercise in obese young males. J Endocrinol 201:151-159
40. Ueno H, Yamaguchi H, Mizuta M, Nakazato M (2008) The role of PYY in feeding regulation. Regul Pept 145:12-16
41. Wing RR, Carrol C, Jeffrey RW (1978) Repeated observation of obese and normal subjects eating in the natural environment. Addict Behav 3:191-196
42. Yoshida T, Sakane N, Umekawa T, Sakai M, Takahashi T, Kondo M (1995) Mutation of beta 3-adrenergic-receptor gene and response to treatment of obesity. Lancet 346:1433-1434